Abbott Laboratories Recalls Raductil due to potential for Severe Side Effects
November 1, 2010 - This week, Abbott Laboratories announced the recall of obesity drug Raductil following its withdrawal from U.S. and Canadian markets at the request of federal health regulators.
Raductil, whose active ingredient is sibutramine hydrochloride, was withdrawn last month after being on the market for 13 years. The FDA’s decision was based on a six-year clinical trial which evaluated the diet drug's cardiovascular safety in high-risk patients, highlighting the risk of heart attacks and strokes.
Have you been harmed by Raductil side effects?
The Defective Drug & Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Raductil side effects lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Free Raductil Side Effects Recall Case Evaluation: If you or a loved one has suffered a heart attack, stroke, or any other adverse side effect after taking Raductil, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.